<?xml version="1.0" encoding="UTF-8"?>
<p id="p0100">DENV is considered as an urban disease, completing its cycle in humans by the biting of mosquito [
 <xref rid="bib76" ref-type="bibr">76</xref>]. Currently, it is vital to develop new antivirus drugs due to the absence of proper treatment or vaccination for DENF [
 <xref rid="bib76" ref-type="bibr">76</xref>]. A known fumiquinozaline, scequinadoline A (
 <bold>75</bold>, 
 <xref rid="fig16" ref-type="fig">Fig. 16</xref> ), was obtained from the marine-derived fungus 
 <italic>Dichotomomyces cejpii</italic> F31-1 isolated from the inner tissue of the soft coral 
 <italic>Lobophytum crassum</italic> which was acquired from Hainan Sanya National Coral Reef Reserve, China [
 <xref rid="bib77" ref-type="bibr">77</xref>]. Compound 
 <bold>75</bold> exerted obvious antivirus activity with 50% inhibition at 50 μM against dengue virus serotype 2 productions by standard plaque assay, equivalent to the positive control andrographlide at the same concentration, showing the potential for further development as a dengue virus inhibitor [
 <xref rid="bib77" ref-type="bibr">77</xref>].
</p>
